ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.848,77
-0,34%
S&P 500
6.041,25
1,12%
Dow Jones
43.320,10
0,05%
Euro vs US Dollar
1,0417
0,17%
Bitcoin
95.867,82
-3,46%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSX

  6. COSCIENS Biopharma Inc (CSCI) Börsenkurse

COSCIENS Biopharma Inc

COSCIENS Biopharma Inc (CSCI)

COSCIENS Biopharma Inc
3,79
0,07
(1,88%)
Geschlossen 26 Dezember 10:12PM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
3,79
Gebot
3,64
Fragen
3,80
Volumen
2.211
3,65 Tagesbereich 3,80
3,65 52-Wochen-Bereich 9,00
Marktkapitalisierung
18,404M
Handelsende
3,72
Handelsbeginn
3,80
Letzte Trade
100
@
3.79
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
2.081
Ausgegebene Aktien
4.856.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,11
Gewinn pro Aktie (EPS)
-3,41
Erlöse
4,5M
Nettogewinn
-16,55M

Über COSCIENS Biopharma Inc

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.zentaris.com/
Hauptsitz
Toronto, Ontario, Can
Gegründet
-
COSCIENS Biopharma Inc is listed in the Pharmaceutical Preparations sector of the Toronto Börse with ticker CSCI. The last closing price for COSCIENS Biopharma was $3,72. Over the last year, COSCIENS Biopharma shares have traded in a share price range of $ 3,65 to $ 9,00.

COSCIENS Biopharma currently has 4.856.000 shares in issue. The market capitalisation of COSCIENS Biopharma is $18,06 million. COSCIENS Biopharma has a price to earnings ratio (PE ratio) of -1.11.

CSCI Neueste Nachrichten

Weitere Nachrichten

COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization

Company leveraging core competencies to develop and commercialize natural-based products to improve health and wellness Streamlined efficiencies and cost cutting measures taken to refine...

23 Dezember 2024
GlobeNewswire Inc.

COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs

Continued execution on merger integration with Ceapro Inc. and advancements across business Company ended the quarter with US$20.0 million in cash TORONTO, ONTARIO, Nov. 12, 2024 (GLOBE...

12 November 2024
GlobeNewswire Inc.

COSCIENS Biopharma Announces Change to Board of Directors

TORONTO, ONTARIO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company developing and...

08 Oktober 2024
GlobeNewswire Inc.

COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director

TORONTO, ONTARIO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company developing and...

01 Oktober 2024
GlobeNewswire Inc.

COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs

TORONTO, ONTARIO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company developing and...

23 September 2024
GlobeNewswire Inc.

COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

- Top-line data with unexpected results requiring further clarification, did not meet primary endpoint as per protocol - Potent growth hormone release following macimorelin stimulation - Safety of...

27 August 2024
GlobeNewswire Inc.

COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results

                Data from pivotal DETECT-Trial evaluating macimorelin for the diagnosis of childhood-onset growth hormone deficiency expected in Q3 2024 Company ended the quarter with US$27.8...

13 August 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.36-8.674698795184.154.153.6521883.8894451CS
4-0.42-9.976247030884.214.453.6523574.05835002CS
12-1.41-27.11538461545.25.223.6520814.36417073CS
26-4.61-54.8809523818.493.6519584.8744108CS
52-4.61-54.8809523818.493.6519584.8744108CS
156-4.61-54.8809523818.493.6519584.8744108CS
260-4.61-54.8809523818.493.6519584.8744108CS

CSCI - Frequently Asked Questions (FAQ)

What is the current COSCIENS Biopharma share price?
The current share price of COSCIENS Biopharma is $ 3,79
How many COSCIENS Biopharma shares are in issue?
COSCIENS Biopharma has 4.856.000 shares in issue
What is the market cap of COSCIENS Biopharma?
The market capitalisation of COSCIENS Biopharma is CAD 18,06M
What is the 1 year trading range for COSCIENS Biopharma share price?
COSCIENS Biopharma has traded in the range of $ 3,65 to $ 9,00 during the past year
What is the PE ratio of COSCIENS Biopharma?
The price to earnings ratio of COSCIENS Biopharma is -1,11
What is the cash to sales ratio of COSCIENS Biopharma?
The cash to sales ratio of COSCIENS Biopharma is 4,09
What is the reporting currency for COSCIENS Biopharma?
COSCIENS Biopharma reports financial results in USD
What is the latest annual turnover for COSCIENS Biopharma?
The latest annual turnover of COSCIENS Biopharma is USD 4,5M
What is the latest annual profit for COSCIENS Biopharma?
The latest annual profit of COSCIENS Biopharma is USD -16,55M
What is the registered address of COSCIENS Biopharma?
The registered address for COSCIENS Biopharma is AETERNA ZENTARIS INC, 222 BAY STREET, SUITE 3000, TORONTO, ONTARIO, M5K 1E7
What is the COSCIENS Biopharma website address?
The website address for COSCIENS Biopharma is www.zentaris.com/
Which industry sector does COSCIENS Biopharma operate in?
COSCIENS Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
GMTNGold Mountain Mining Corp
$ 0,035
(16,67%)
10k
XLYAuxly Cannabis Group Inc
$ 0,035
(16,67%)
378,93k
PPRPrairie Provident Resources Inc
$ 0,035
(16,67%)
390k
WRXWestern Resources Corp
$ 0,04
(14,29%)
3k
GFRGreenfire Resources Ltd
$ 10,09
(13,37%)
31,9k
RTGRTG Mining Inc
$ 0,025
(-37,50%)
100k
NCFNorthcliff Resources Ltd
$ 0,02
(-20,00%)
1,03M
KLSKelso Technologies Inc
$ 0,11
(-15,38%)
3,5k
AVLAvalon Advanced Materials Inc
$ 0,035
(-12,50%)
114k
YRBYorbeau Resources Inc
$ 0,035
(-12,50%)
110k
TTelus Corp
$ 19,45
(-1,52%)
4,87M
BBBlackBerry Limited
$ 5,65
(4,05%)
3,61M
ABXBarrick Gold Corporation
$ 22,55
(0,71%)
3,57M
BITFBitfarms Ltd
$ 2,45
(6,06%)
3,26M
FCUFission Uranium Corp
$ 0,72
(-2,70%)
2,54M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TSX
CSCI
COSCIENS Biopharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten